Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants

Background and Purpose— Thrombolysis in patients using oral anticoagulants (OAC) and in patients for whom information on OAC status is not available is frequently delayed because the standard coagulation analysis procedure in central laboratories (CL) is time-consuming. By using point-of-care (POC) coagumeters, international normalized ratio (INR) values can be measured immediately at the bedside. The accuracy and effectiveness of POC devices for emergency management in acute ischemic stroke has not been tested. Methods— In phase 1, the reliability of emergency INR POC measurements in comparison to CL was determined. In phase 2, patients with ischemic stroke admitted within the time frame for systemic thrombolysis and who were either using OAC or for whom information on OAC status was not available were enrolled. Patients received thrombolysis if POC INR was ≤1.5. Precision and time gain was recorded for INR as measured by POC vs CL. Results— In phase 1 (n=113), Bland-Altman analysis showed close agreement between POC and CL, and Pearson correlation was highly significant (r=0.98; P<0.01). In phase 2, 48 patients were included, of whom 70.8% were using OAC; 23 patients received thrombolysis. After subtracting the time needed for the diagnostic work-up, the net time gain was 28±12 minutes (mean±SD). Conclusions— Measuring INR by POC in an emergency setting is sufficiently precise in OAC acute stroke patients and substantially reduces the time interval until INR values are available and therefore may hasten the initiation of thrombolysis.

[1]  W. Wuillemin,et al.  INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation. , 2007, Thrombosis research.

[2]  M. Hill,et al.  Reliability of Point-of-Care Testing of INR in Acute Stroke , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[3]  Gary A. Ford,et al.  Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. , 2008, Cerebrovascular diseases.

[4]  H. Völler,et al.  Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. , 2005, International journal of cardiology.

[5]  J. Saver Time Is Brain—Quantified , 2006, Stroke.

[6]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[7]  Mark Crowther,et al.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[8]  R. Grubb,et al.  Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.

[9]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[10]  D. Altman,et al.  Applying the right statistics: analyses of measurement studies , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[11]  D. Arnar,et al.  [Prevalence of atrial fibrillation and use of warfarin among patients with ischemic stroke.]. , 2004, Laeknabladid.

[12]  S. Byrne,et al.  The reliability of point‐of‐care prothrombin time testing. A comparison of CoaguChek S® and XS® INR measurements with hospital laboratory monitoring , 2010, International journal of laboratory hematology.

[13]  David J. Gladstone,et al.  Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated , 2009, Stroke.

[14]  M. Moia,et al.  Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter study. , 2000, Thrombosis research.

[15]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[16]  S. Rangarajan,et al.  Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  M. Aguilar,et al.  Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. , 2005, The Cochrane database of systematic reviews.

[18]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[19]  S. Lydersen,et al.  Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation , 2005, Journal of internal medicine.

[20]  Kamakshi Lakshminarayan,et al.  Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002) , 2006, Stroke.

[21]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[22]  M. Prins,et al.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison , 2000, The Lancet.

[23]  D. Newman,et al.  The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department. , 2006, Annals of emergency medicine.

[24]  K. Furie,et al.  Admission international normalized ratio and acute infarct volume in ischemic stroke , 2008, Annals of neurology.